Dolasetron. A new 5-hydroxytryptamine3 receptor antagonist.

Article Details

Citation

Copy to clipboard

Hui YF, Ignoffo RJ

Dolasetron. A new 5-hydroxytryptamine3 receptor antagonist.

Cancer Pract. 1997 Sep-Oct;5(5):324-8.

PubMed ID

9341357 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Dolasetron	5-hydroxytryptamine receptor 3A	Protein	Humans	Yes	Antagonist	Details